Insider trade

Cencora (COR): CEO sold ~$1.48M

Robert P. Mauch, CEO at Cencora, sold ~$1.48M of Cencora shares.

~$1.48M
Approx. value · 5,097 sh @ $290.00
39K
Holds after · shares reported
Traded
Sep 18, 2025
Filed
Sep 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
  2. Jul 22, 2025InsiderChair sold ~$4.27M of COR shares in the open market
  3. Jul 29, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [6…
  4. Aug 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
  5. Aug 19, 2025InsiderChair sold ~$4.23M of COR shares in the open market
  6. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
  7. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. 50 Tablet…
  8. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217…
  9. Aug 27, 2025FDARecall: chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10)…
  10. Sep 5, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  11. Sep 15, 2025FDARecall: Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carto…
  12. Sep 16, 2025InsiderChair sold ~$9.09M of COR shares in the open market
  13. Sep 18, 2025 · this disclosureInsiderCEO sold ~$1.48M of COR shares in the open market

What came next

  1. Oct 1, 2025InsiderOfficer sold ~$591K of COR shares in the open market
  2. Oct 9, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC […
  3. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 606…
  4. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
  5. Oct 16, 2025FDARecall: Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC…
  6. Oct 20, 2025InsiderCEO sold ~$1.67M of COR shares in the open market
  7. Nov 5, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  8. Nov 18, 2025InsiderCEO sold ~$1.87M of COR shares in the open market
  9. Dec 17, 2025InsiderOfficer sold ~$1.38M of COR shares in the open market
  10. Dec 18, 2025InsiderCEO sold ~$1.75M of COR shares in the open market
  11. Dec 19, 2025Insider · 2 peopleInsiders: 2 sales (~$1.7M)
  12. Jan 12, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  13. Jan 14, 2026FDARecall: Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package is from NDC…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Robert P. Mauch, President & CEO

The full history of Robert P. Mauch, President & CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Cencora (COR) insider traded, and how much?

Robert P. Mauch, CEO at Cencora, sold ~$1.48M of Cencora shares. 5,097 shares at $290.00.

When did it happen, and when was it made public?

Traded: Sep 18, 2025. Filed: Sep 22, 2025. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Cencora recently?

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the COR page.

Does this mean COR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data